SN
Sonoma Pharmaceuticals, Inc.
SNOA · NASDAQ
$1.31 -2.61% (-$0.04)
1M +0.77%
Market Cap $2.21M
P/E Ratio -
Div. Yield -
ROE 53.56%
Bulios Fair Price
$1.89
44.8% upside
Trenutna cena
$1.31
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNOA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.10x
P/B 0.33x
P/E N/A
Growth
64 /100
Stable Rev. growth 13.74%
Book val. growth 27.06%
EPS growth N/A
Profitability
15 /100
Weak Gross margin 38.91%
Net margin 10.33%
Op. margin 6.41%
Quality
15 /100
Poor ROIC 9.80%
ROE 53.56%
ROA 12.50%
Debt
100 /100
Low Debt/Equity 0.11x
Current ratio 2.99x
Int. coverage N/A
Stability
59 /100
Moderate Beta 1.31x
Rev. volatility 20.50%
EPS volatility 16.36%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNOA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Amy Trombly
Employees
10
Headquarters
Boulder
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report